Adaptive Immunity to Dengue Virus: Slippery Slope or Solid Ground for Rational Vaccine Design?

por Wilken, Lucas, Rimmelzwaan, Guus F.
Publicado 2020

Viral vector-based influenza vaccines

por de Vries, Rory D., Rimmelzwaan, Guus F.
Publicado 2016

Influenza Virus Infections and Cellular Kinases

por Meineke, Robert, Rimmelzwaan, Guus F., Elbahesh, Husni
Publicado 2019

Response Modifiers: Tweaking the Immune Response Against Influenza A Virus

por Elbahesh, Husni, Gerlach, Thomas, Saletti, Giulietta, Rimmelzwaan, Guus F.
Publicado 2019

Age distribution of cases caused by different influenza viruses

por Rimmelzwaan, Guus F, Fouchier, Ron AM, Osterhaus, Albert DME
Publicado 2013

ADCC: An underappreciated correlate of cross-protection against influenza?

por de Vries, Rory D., Hoschler, Katja, Rimmelzwaan, Guus F.
Publicado 2023

Transient Blockade of Type I Interferon Signalling Promotes Replication of Dengue Virus Strain D2Y98P in Adult Wild-Type Mice

por Wilken, Lucas, Stelz, Sonja, Prajeeth, Chittappen Kandiyil, Rimmelzwaan, Guus F.
Publicado 2023

Targets for the Induction of Protective Immunity Against Influenza A Viruses

por Bodewes, Rogier, Osterhaus, Albert D.M.E, Rimmelzwaan, Guus F.
Publicado 2010

Advances in influenza vaccination

por Reperant, Leslie A., Rimmelzwaan, Guus F., Osterhaus, Albert D.M.E.
Publicado 2014

Developing Universal Influenza Vaccines: Hitting the Nail, Not Just on the Head

por Wiersma, Lidewij C. M., Rimmelzwaan, Guus F., de Vries, Rory D.
Publicado 2015

Induction of Virus-Specific Cytotoxic T Lymphocytes as a Basis for the Development of Broadly Protective Influenza Vaccines

por Hillaire, Marine L. B., Osterhaus, Albert D. M. E., Rimmelzwaan, Guus F.
Publicado 2011

Rift Valley Fever Virus—Infection, Pathogenesis and Host Immune Responses

por Nair, Niranjana, Osterhaus, Albert D. M. E., Rimmelzwaan, Guus F., Prajeeth, Chittappen Kandiyil
Publicado 2023

Evasion of Influenza A Viruses from Innate and Adaptive Immune Responses

por van de Sandt, Carolien E., Kreijtz, Joost H. C. M., Rimmelzwaan, Guus F.
Publicado 2012

Tick-Borne Encephalitis Virus: A Quest for Better Vaccines against a Virus on the Rise

por Kubinski, Mareike, Beicht, Jana, Gerlach, Thomas, Volz, Asisa, Sutter, Gerd, Rimmelzwaan, Guus F.
Publicado 2020

Recombinant Modified Vaccinia Virus Ankara Expressing a Glycosylation Mutant of Dengue Virus NS1 Induces Specific Antibody and T-Cell Responses in Mice

por Wilken, Lucas, Stelz, Sonja, Agac, Ayse, Sutter, Gerd, Prajeeth, Chittappen Kandiyil, Rimmelzwaan, Guus F.
Publicado 2023

Response to 2009 Pandemic Influenza A (H1N1) Vaccine in HIV-Infected Patients and the Influence of Prior Seasonal Influenza Vaccination

por Soonawala, Darius, Rimmelzwaan, Guus F., Gelinck, Luc B. S., Visser, Leo G., Kroon, Frank P.
Publicado 2011

Effect of Travel on Influenza Epidemiology

por Belderok, Sanne-Meike, Rimmelzwaan, Guus F., van den Hoek, Anneke, Sonder, Gerard J.B.
Publicado 2013

Influenza Vaccines: Successes and Continuing Challenges

por Becker, Tanja, Elbahesh, Husni, Reperant, Leslie A, Rimmelzwaan, Guus F, Osterhaus, Albert D M E
Publicado 2021

Influenza in long-term Dutch travelers in the tropics: symptoms and infections

por Whelan, Jane, Rimmelzwaan, Guus F., van den Hoek, Anneke, Belderok, Sanne-Meike, Sonder, Gerard J. B.
Publicado 2016

FDA-approved Abl/EGFR/PDGFR kinase inhibitors show potent efficacy against pandemic and seasonal influenza A virus infections of human lung explants

por Meineke, Robert, Stelz, Sonja, Busch, Maximilian, Werlein, Christopher, Kühnel, Mark, Jonigk, Danny, Rimmelzwaan, Guus F., Elbahesh, Husni
Publicado 2023